Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
CRL Charles River Laboratories International, Inc. monthly Stock Chart
CRL [NYSE]
Charles River Laboratories International, Inc.
Healthcare | Diagnostics & Research | USA
statements
Index- P/E39.90 EPS (ttm)5.43 Insider Own1.50% Shs Outstand49.55M Perf Week-1.29%
Market Cap10.70B Forward P/E25.70 EPS next Y8.43 Insider Trans-11.35% Shs Float48.93M Perf Month-0.84%
Income271.40M PEG3.53 EPS next Q1.79 Inst Own96.60% Short Float1.27% Perf Quarter27.53%
Sales2.75B P/S3.89 EPS this Y13.30% Inst Trans-0.23% Short Ratio1.79 Perf Half Y71.73%
Book/sh35.37 P/B6.13 EPS next Y16.16% ROA5.50% Target Price238.00 Perf Year60.30%
Cash/sh8.16 P/C26.55 EPS next 5Y11.31% ROE16.50% 52W Range95.58 - 228.86 Perf YTD41.90%
Dividend- P/FCF25.72 EPS past 5Y13.40% ROI8.50% 52W High-5.28% Beta1.15
Dividend %- Quick Ratio1.50 Sales past 5Y15.10% Gross Margin36.10% 52W Low126.79% ATR6.27
Employees17100 Current Ratio1.70 Sales Q/Q3.80% Oper. Margin13.60% RSI (14)53.26 Volatility3.29% 3.01%
OptionableYes Debt/Eq1.29 EPS Q/Q52.40% Profit Margin9.90% Rel Volume0.52 Prev Close211.83
ShortableYes LT Debt/Eq1.26 EarningsAug 05 BMO Payout0.00% Avg Volume346.81K Price216.77
Recom1.70 SMA200.54% SMA502.60% SMA20027.56% Volume180,065 Change2.33%
Sep-10-20Upgrade Jefferies Hold → Buy $254
Jul-01-20Upgrade BofA Securities Neutral → Buy $192
May-13-20Upgrade UBS Neutral → Buy $177 → $200
Apr-21-20Downgrade Jefferies Buy → Hold $139
Mar-27-20Upgrade Morgan Stanley Equal-Weight → Overweight $152
Mar-02-20Initiated Deutsche Bank Buy $190
Feb-18-20Upgrade Wolfe Research Peer Perform → Outperform
Jan-10-20Upgrade Goldman Neutral → Buy $143 → $179
Jan-08-20Initiated Wells Fargo Overweight $180
Jan-07-20Initiated Citigroup Buy $185
Oct-18-19Downgrade BofA/Merrill Buy → Neutral $150
Jun-10-19Initiated SVB Leerink Outperform $155
Apr-30-19Resumed Evercore ISI Outperform $160
Dec-14-18Initiated Deutsche Bank Buy
Oct-09-18Initiated UBS Neutral
Aug-23-18Upgrade Raymond James Mkt Perform → Outperform
Jul-17-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Jun-15-18Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
Feb-14-18Upgrade SunTrust Hold → Buy
Jan-22-18Downgrade SunTrust Buy → Hold
Sep-26-20 09:51AM  
How Good Is Charles River Laboratories International, Inc. (NYSE:CRL), When It Comes To ROE?
Simply Wall St.
Sep-23-20 11:49AM  
Western Digital Stock Spikes On Speculation It May Split Into Two
Barrons.com
Sep-21-20 02:52PM  
Buy Western Digital Stock, Analyst Says. Kioxias IPO Will Show Its True Valuation.
Barrons.com
Sep-15-20 04:03PM  
Charles River Labs Shakes Off Covid-19 Impact To Record High And Stock Of The Day
Investor's Business Daily
03:11PM  
Stocks Climb Broadly But Apple Quiet After It Unveils Products
Investor's Business Daily
02:25PM  
Charles River Labs Shakes Off Covid-19 Impact To Record High And Stock Of The Day
Investor's Business Daily
11:36AM  
Charles River Labs Breaks Out
Investor's Business Daily Video
Sep-13-20 08:00PM  
Market Digest: GNRC, AAP, CRL, LULU, RY, EXC
Argus Research
08:00PM  
Analyst Report: Charles River Laboratories Int
Argus Research
Sep-09-20 09:35AM  
Hedge Funds Have Never Been This Bullish On Charles River Laboratories (CRL)
Insider Monkey
Sep-08-20 08:30AM  
Charles River Laboratories to Present at September Investor Conferences
Business Wire
Aug-31-20 08:59AM  
How Is Charles River Laboratories International's (NYSE:CRL) CEO Paid Relative To Peers?
Simply Wall St.
Aug-28-20 11:20AM  
Edited Transcript of CRL.N earnings conference call or presentation 6-Nov-19 2:00pm GMT
Thomson Reuters StreetEvents
Aug-24-20 02:08PM  
Toshiba Corporation -- Moody's announces completion of a periodic review of ratings of Toshiba Corporation
Moody's
Aug-07-20 02:00AM  
World's First Development and Demonstration of a Quantum Cryptographic Communication Technology Applied System for Genomic Medicine
PR Newswire
Aug-05-20 05:00PM  
Charles River Laboratories International Inc (CRL) Q2 2020 Earnings Call Transcript
Motley Fool +6.89%
09:05AM  
Charles River Laboratories (CRL) Q2 Earnings and Revenues Beat Estimates
Zacks
07:53AM  
Charles River: Q2 Earnings Insights
Benzinga
07:21AM  
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Could Be 34% Above Their Intrinsic Value Estimate
Simply Wall St.
07:00AM  
Charles River Laboratories Announces Second-Quarter 2020 Results
Business Wire
Aug-04-20 05:53PM  
Agilent Technologies At Upper End Of Buy Range With Earnings Due
Investor's Business Daily
05:39PM  
Luminex Scores Relative Strength Rating Upgrade
Investor's Business Daily
09:41AM  
Healthcare Stock Q2 Earnings Roster for Aug 5: HUM, CRL & More
Zacks
09:07AM  
Should You Buy Charles River Laboratories (CRL) Ahead of Earnings?
Zacks
Jul-31-20 12:32PM  
Should Investors Buy the Dip in Charles River Laboratories (CRL) Stock?
Insider Monkey
Jul-29-20 12:33PM  
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy?
Zacks
Jul-24-20 07:39PM  
Charles River Labs International Trading In New Buy Range With Quarterly Report On Tap
Investor's Business Daily
Jul-22-20 09:19AM  
Farallon plans to vote for the shareholder proposals at Toshiba's 181st Annual General Meeting
PR Newswire
Jul-20-20 12:10PM  
Can Charles River (CRL) Keep the Earnings Surprise Streak Alive?
Zacks
Jul-15-20 04:42PM  
IBD Stock Of The Day: Why This Medical Player Isn't Sweating The Pandemic
Investor's Business Daily
Jul-14-20 08:30AM  
Charles River Laboratories Schedules Second-Quarter 2020 Earnings Release and Conference Call
Business Wire
Jul-13-20 05:03PM  
Did Hedge Funds Make The Right Call On Charles River Laboratories International Inc. (CRL) ?
Insider Monkey
Jul-09-20 03:24PM  
The Charles River Laboratories International (NYSE:CRL) Share Price Is Up 147% And Shareholders Are Boasting About It
Simply Wall St.
Jun-15-20 09:59AM  
Edited Transcript of CRL earnings conference call or presentation 7-May-20 1:30pm GMT
Thomson Reuters StreetEvents
Jun-11-20 10:05AM  
Zacks.com featured highlights include: Lowes Companies, Charles River Laboratories International, Agilent Technologies and East West
Zacks
09:02AM  
Moving Average Crossover Alert: Charles River Laboratories International
Zacks
Jun-10-20 10:25AM  
4 GARP Stocks to Scoop Up for Maximum Returns
Zacks
Jun-03-20 02:46AM  
Hedge Funds Never Been This Bullish On Charles River Laboratories International (CRL)
Insider Monkey
Jun-02-20 08:00AM  
HemaCare Adds GMPrimeTM Cryopreserved Leukopak to its GMP Product Portfolio
Business Wire
07:58AM  
Charles River Laboratories' Shares March Higher, Can It Continue?
Zacks
Jun-01-20 08:00AM  
Charles River Laboratories to Participate in Jefferies and William Blair Conferences
Business Wire
May-30-20 10:54PM  
Drugs standards group nixes plan to kick pharma's crab blood habit
Reuters
11:42AM  
Drugs standards group nixes plan to kick pharma's crab blood habit
Reuters
May-28-20 11:00AM  
Shinshu University and Toshiba Develop Tumor-Tropic Liposome Technology that Carries Therapeutic Genes into Cancer Cells
PR Newswire
May-21-20 07:13AM  
A Rising Share Price Has Us Looking Closely At Charles River Laboratories International, Inc.'s (NYSE:CRL) P/E Ratio
Simply Wall St.
May-09-20 09:12AM  
At US$160, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List?
Simply Wall St.
May-08-20 12:31AM  
Charles River Laboratories International Inc (CRL) Q1 2020 Earnings Call Transcript
Motley Fool
May-07-20 08:25AM  
Charles River Laboratories (CRL) Q1 Earnings and Revenues Surpass Estimates
Zacks +8.98%
07:00AM  
Charles River Laboratories Announces First-Quarter 2020 Results
Business Wire
Apr-30-20 12:34PM  
Charles River Laboratories (CRL) Reports Next Week: Wall Street Expects Earnings Growth
Zacks
Apr-29-20 12:08PM  
Why Horizon Kinetics is Bullish on Charles River Laboratories (CRL) Stock?
Insider Monkey
Apr-20-20 03:24PM  
Earnings Season Preview: Medpace Near Buy Zone With Quarterly Report Due
Investor's Business Daily
Apr-19-20 03:54PM  
Covid-19 Shines Spotlight on Clarivate
GuruFocus.com
Apr-16-20 08:40AM  
How Does Charles River Laboratories International's (NYSE:CRL) P/E Compare To Its Industry, After Its Big Share Price Gain?
Simply Wall St.
08:30AM  
Charles River Laboratories Schedules First-Quarter 2020 Earnings Release and Conference Call
Business Wire
Mar-30-20 08:30AM  
Charles River Laboratories and Deciphex Form a Partnership to Enhance Drug Discovery & Development With Digital Pathology
Business Wire
Mar-25-20 06:26AM  
How Does Charles River Laboratories International's (NYSE:CRL) P/E Compare To Its Industry, After The Share Price Drop?
Simply Wall St. +8.38%
Mar-22-20 10:56PM  
Is Charles River Laboratories International Inc. (CRL) Relatively A Good Stock To Buy?
Insider Monkey
Mar-10-20 08:30AM  
Charles River Laboratories To Participate In Barclays Global Healthcare Conference
Business Wire
Mar-04-20 08:00AM  
Charles River Laboratories Adds Nancy C. Andrews, M.D., Ph.D., to Board of Directors
Business Wire
Feb-14-20 09:31AM  
Edited Transcript of CRL earnings conference call or presentation 11-Feb-20 1:30pm GMT
Thomson Reuters StreetEvents
Feb-13-20 07:11AM  
What Did Charles River Laboratories International, Inc.'s (NYSE:CRL) CEO Take Home Last Year?
Simply Wall St.
06:37AM  
Charles River Laboratories International, Inc. Analysts Are Pretty Bullish On The Stock After Recent Results
Simply Wall St.
Feb-12-20 12:00PM  
Here's Why Momentum Investors Will Love Charles River Laboratories (CRL)
Zacks
10:30AM  
Charles River Labs Soars to a New High and More Strength Is Coming
TheStreet.com
09:15AM  
Charles River (CRL) Hits Fresh High: Is There Still Room to Run?
Zacks
Feb-11-20 09:19AM  
Charles River Laboratories Reports Q4 Above Our Expectations; Raising FVE on Solid 2020 Guidance
Morningstar +9.88%
08:25AM  
Charles River Laboratories (CRL) Q4 Earnings and Revenues Beat Estimates
Zacks
07:00AM  
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2019 Results and Provides 2020 Guidance
Business Wire
Feb-06-20 09:18AM  
Zacks.com featured highlights include: MSFT, RUTH, RMD, CDNS, CRL and MXIM
Zacks
Feb-05-20 08:44AM  
6 GARP Stocks to Scoop Up for Maximum Returns
Zacks
Feb-04-20 12:30PM  
Charles River Laboratories (CRL) Earnings Expected to Grow: Should You Buy?
Zacks
Jan-22-20 07:46AM  
Zacks.com featured highlights include: Design System, The Toro Company, Charles River Laboratories International and ICON
Zacks
Jan-21-20 04:30PM  
Charles River Laboratories Schedules Fourth-Quarter 2019 Earnings and 2020 Guidance Release and Conference Call
Business Wire
09:11AM  
4 GARP Stocks for a Winning Portfolio
Zacks
Jan-19-20 08:16AM  
Here's Why We Think Charles River Laboratories International (NYSE:CRL) Is Well Worth Watching
Simply Wall St.
Jan-17-20 03:34PM  
Still Time to Ride the Wave With Charles River
GuruFocus.com
09:15AM  
Icon PLC (ICLR) Hits Fresh High: Is There Still Room to Run?
Zacks
Jan-16-20 08:00AM  
Charles River Laboratories and Fios Genomics Form a Strategic Alliance to Provide Bioinformatics-driven Drug Discovery and Safety Assessment
Business Wire
Jan-15-20 12:10PM  
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
Zacks
Jan-13-20 08:30AM  
Charles River and Takeda Announce Scientific Collaboration to Identify and Develop Preclinical Candidates
Business Wire
08:00AM  
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
Business Wire
Jan-08-20 09:15AM  
Charles River (CRL) Soars to 52-Week High, Time to Cash Out?
Zacks
Jan-07-20 11:50AM  
Top-Rated Stocks: Charles River Labs International Sees Composite Rating Climb To 96
Investor's Business Daily
Jan-03-20 08:30AM  
Charles River Laboratories Completes the Acquisition of HemaCare Corporation
Business Wire
Dec-26-19 10:56AM  
How Did Charles River Laboratories International Inc. (CRL) Compare Against Top Hedge Fund Stocks in 2019?
Insider Monkey
Dec-24-19 06:44AM  
Is Charles River Laboratories International, Inc.'s (NYSE:CRL) P/E Ratio Really That Good?
Simply Wall St.
Dec-18-19 07:35PM  
SHAREHOLDER ALERT: WeissLaw LLP Investigates HemaCare Corporation
PR Newswire
Dec-16-19 02:33PM  
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HemaCare Corporation
PR Newswire
07:00AM  
Charles River Laboratories to Acquire HemaCare Corporation
Business Wire
Dec-10-19 08:00AM  
Charles River Announces Strategic Partnership with Bit Bio, Increasing Portfolio of Translational Drug Discovery Technologies
Business Wire
07:51AM  
Devon Park Drive building hits the market, could sell for a big premium
American City Business Journals
Dec-09-19 04:30PM  
Distributed Bio Launches Cosmic Antibody Library, Provides Charles River Clients Exclusive Access
Business Wire
Dec-04-19 04:30PM  
Charles River Laboratories Updates Tumor Model Compendium
Business Wire
Dec-03-19 10:02AM  
Hedge Funds Have Never Been This Bullish On Charles River Laboratories International Inc. (CRL)
Insider Monkey
Nov-28-19 05:40AM  
Can You Imagine How Chuffed Charles River Laboratories International's (NYSE:CRL) Shareholders Feel About Its 130% Share Price Gain?
Simply Wall St.
Nov-12-19 04:36AM  
Charles River Labs Won't See Its Narrow Trading Range Last Forever
TheStreet.com
Nov-11-19 08:30AM  
Charles River Laboratories to Present at Upcoming Investor Conferences
Business Wire
Nov-06-19 08:35AM  
Charles River Laboratories (CRL) Q3 Earnings Beat Estimates
Zacks
07:00AM  
Charles River Laboratories Announces Third-Quarter 2019 Results
Business Wire
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily purpose-bred rats and mice for use by researchers. It also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification of a druggable target through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as bioanalysis, drug metabolism, pharmacokinetics, safety pharmacology, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. It also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MASSARO GEORGEDirectorSep 14Sale219.911,943427,2849,441Sep 15 05:47 PM
Girshick BirgitCorporate Executive VPAug 20Sale213.51933199,20522,852Aug 21 10:48 AM
CHUBB STEPHEN DDirectorAug 18Sale217.651,000217,65137,657Aug 19 02:48 PM
Knell Michael GunnarCSVP&Chief Accounting OfficerAug 07Option Exercise111.413,441383,3535,855Aug 10 03:20 PM
Smith David RossCorporate Executive VP & CFOAug 07Option Exercise144.673,304477,99024,071Aug 10 04:18 PM
Kochevar Deborah TurnerDirectorAug 07Sale216.242,319501,4676,728Aug 11 10:39 AM
FOSTER JAMES CChairman, President and CEOAug 07Sale217.4924,0005,219,771210,777Aug 10 04:25 PM
Knell Michael GunnarCSVP&Chief Accounting OfficerAug 07Sale216.603,456748,5552,399Aug 10 03:20 PM
Smith David RossCorporate Executive VP & CFOAug 07Sale216.543,304715,44420,767Aug 10 04:18 PM
MASSARO GEORGEDirectorMay 22Sale173.40941163,16811,884May 26 02:37 PM
BERTOLINI ROBERT JDirectorMay 20Option Exercise52.293,530184,58432,664May 21 11:36 AM
BERTOLINI ROBERT JDirectorMay 20Sale174.583,530616,26329,134May 21 11:36 AM
LaPlume Joseph WEVP, Corp Strategy & DevelopMay 18Sale174.6535061,1289,637May 19 04:18 PM
FOSTER JAMES CChairman, President and CEOMay 18Sale175.0017,4353,051,125229,894May 19 04:14 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopMay 15Option Exercise80.486,350511,04525,405May 19 04:18 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopMay 15Sale168.2615,4182,594,1709,987May 19 04:18 PM
Girshick BirgitCorporate Executive VPMay 12Sale165.74780129,27721,837May 13 08:18 AM
FOSTER JAMES CChairman, President and CEOMay 11Sale162.5317,4462,835,433249,329May 13 11:02 AM
Smith David RossCorporate Executive VP & CFOMay 07Sale150.001,884282,60018,591May 08 10:48 AM
Barbo William DCorporate Executive VP & CCOMar 05Option Exercise102.5612,4671,278,67730,201Mar 06 03:50 PM
Barbo William DCorporate Executive VP & CCOMar 05Sale164.3513,9662,295,30016,235Mar 06 03:50 PM
CHUBB STEPHEN DDirectorFeb 27Option Exercise55.177,170395,57242,005Feb 28 10:28 AM
CHUBB STEPHEN DDirectorFeb 27Sale160.892,464396,43739,541Feb 28 10:28 AM
FOSTER JAMES CChairman, President and CEOFeb 26Option Exercise73.7025,1241,851,639311,899Feb 27 02:45 PM
Smith David RossCorporate Executive VP & CFOFeb 26Option Exercise73.704,188308,65624,663Feb 27 02:48 PM
FOSTER JAMES CChairman, President and CEOFeb 26Sale162.2525,1244,076,411286,775Feb 27 02:45 PM
Smith David RossCorporate Executive VP & CFOFeb 26Sale162.264,188679,53520,475Feb 27 02:48 PM
Smith David RossCorporate Executive VP & CFOFeb 24Option Exercise98.028,211804,86029,065Feb 25 11:29 AM
FOSTER JAMES CChairman, President and CEOFeb 24Option Exercise97.8044,3034,332,960333,349Feb 26 10:15 AM
FOSTER JAMES CChairman, President and CEOFeb 24Sale167.833,000503,490750Feb 26 10:15 AM
FOSTER JAMES CChairman, President and CEOFeb 24Sale166.7044,3037,385,433289,046Feb 26 10:15 AM
Smith David RossCorporate Executive VP & CFOFeb 24Sale166.728,2111,368,95320,854Feb 25 11:29 AM
MILNE GEORGE M JRDirectorFeb 18Option Exercise55.177,170395,57234,207Feb 19 10:41 AM
MILNE GEORGE M JRDirectorFeb 18Sale176.077,1701,262,43027,037Feb 19 10:41 AM
WALLMAN RICHARD FDirectorFeb 14Option Exercise52.293,530184,58432,897Feb 14 05:10 PM
WALLMAN RICHARD FDirectorFeb 14Sale174.293,530615,25829,367Feb 14 05:10 PM
BERTOLINI ROBERT JDirectorFeb 13Option Exercise55.177,170395,57235,045Feb 14 12:24 PM
WALLMAN RICHARD FDirectorFeb 13Option Exercise55.177,170395,57236,537Feb 14 05:07 PM
FOSTER JAMES CChairman, President and CEOFeb 13Sale171.9015,0002,578,440298,064Feb 14 03:06 PM
Girshick BirgitCorporate Executive VPFeb 13Sale172.05900154,84523,714Feb 14 09:43 AM
Smith David RossCorporate Executive VP & CFOFeb 13Sale170.294,500766,31921,978Feb 13 07:08 PM
WALLMAN RICHARD FDirectorFeb 13Sale172.027,1701,233,39129,367Feb 14 05:07 PM
BERTOLINI ROBERT JDirectorFeb 13Sale170.417,1701,221,81927,875Feb 14 12:24 PM
Barbo William DCorporate Executive VP & CCOFeb 13Sale172.116,9011,187,69918,931Feb 14 12:01 PM
JOHST DAVID PCorporate Executive VPDec 09Option Exercise76.6724,6601,890,682237,514Dec 11 10:36 AM
JOHST DAVID PCorporate Executive VPDec 09Sale144.2124,6603,556,341212,854Dec 11 10:36 AM
Girshick BirgitCorporate Executive VPDec 09Sale145.551,051152,97217,715Dec 10 05:00 PM
Girshick BirgitCorporate Executive VPDec 09Sale144.932,874416,51618,766Dec 10 04:58 PM
Girshick BirgitCorporate Executive VPDec 09Sale144.212,420348,99321,640Dec 10 04:55 PM
Girshick BirgitCorporate Executive VPNov 13Option Exercise91.199,604875,77833,664Nov 14 05:21 PM
Girshick BirgitCorporate Executive VPNov 13Sale137.231,499205,71224,060Nov 14 05:23 PM
Girshick BirgitCorporate Executive VPNov 13Sale137.048,1051,110,71725,559Nov 14 05:21 PM
open in yahoo | open in reuters | open in google